Proposed changes to the Permissible Indications Determination - Page 1 of 11 - Therapeutic Goods Administration

Page 1 of 11

Introduction

What is your name?

Name (Required)

What is your email address?

Email (Required)

Please indicate, from the list below, the capacity in which you are responding (e.g. organisation, business or individual).

(Required) Peak body Health professional Sponsor Manufacturer Consumers As an individual Other

Details of the organisation or business (if applicable)